Rochester, United States
Research view
Amyloidosis: who works on it
Groups that published on this disease or run trials on it, from public registries and publications. Researchers appear by name only once their profile is published.
Find fellow researchers
One card per institution. Filter by target, by country, or show only institutions in EU-13 (Horizon Europe widening) countries.
EU-13 is a filter, not a ranking: it only narrows the list.
London, United Kingdom
New York, United States
Cleveland, United States
Cambridge, United States
Boston, United States
London, United Kingdom
Paris, France
Boston, United States
Stanford, United States
Pavia, Italy
Boston, United States
Paris, France
Créteil, France
Pavia, Italy
Pisa, Italy
Athens, Greece
Stanford, United States
Créteil, France
Beijing, China
Cambridge, United States
Pisa, Italy
Vienna, Austria
Rome, Italy
24 of 200+ institutions, ordered by recent publications and open trials. This is not a ranking of quality.
Who stopped a trial, and why
Terminated, withdrawn and suspended trials with the reason the sponsor gave in the registry, quoted word for word.
Withdrawn
A Study Investigating Coagadex in the Treatment AFXD Associated With AL Amyloidosis
“Study was discontinued for non-safety reasons and the rapidly evolving treatment landscape for AL amyloidosis.”Registry text, quoted unchanged. Source
Terminated
Open-Label Study of AG10 in Patients With Cardiomyopathy
“Study ended by the sponsor due to meeting Study Objectives”Registry text, quoted unchanged. Source
Withdrawn
“Due to the promulgation of State Council Order No. 818, clinical trials of this category are prohibited.”Registry text, quoted unchanged. Source
Withdrawn
Autologous BCMA-targeted CAR-T Cell Injection for Relapsed/Refractory Light Chain Amyloidosis
“Due to the promulgation of State Council Order No. 818, clinical trials of this category are prohibited.”Registry text, quoted unchanged. Source
Withdrawn
“Merged with other trial”Registry text, quoted unchanged. Source
Withdrawn
“Study withdrawn before enrollment due to protocol and consent-related issues identified during the study preparation phase.”Registry text, quoted unchanged. Source
Suspended
Post Approval Study of Lixelle for the Treament of Dialysis-Related Amyloidosis
“Ongoing adjustments”Registry text, quoted unchanged. Source
Withdrawn
“The study protocol was withdrawn because, after modifications, the study transitioned from an Investigator-Initiated Trial (IIT) to an Investigational New Drug (IND) clinical trial. This change necessitated a multi-center approach.”Registry text, quoted unchanged. Source
Withdrawn
ION-682884 in Patients With TTR Amyloid Cardiomyopathy
“no subjects available”Registry text, quoted unchanged. Source
Terminated
Transthyretin Amyloidosis Cardiomyopathy in Patients With HFpEF in Russia
“The study was suspended after interim analysis to confirm reasonability of further investigation of the population”Registry text, quoted unchanged. Source
Trials that share participant data
Trials whose registry record says individual participant data (IPD) will be shared.
Search by method
Find publications on this disease by a MeSH method term, for example a sequencing or imaging method.
- Single-Cell Analysis 1
- Mendelian Randomization Analysis 1
- CRISPR-Cas Systems 3
- Gene Expression Profiling 3
- Sequence Analysis, RNA 3
- Exome Sequencing 3
- Proteomics 20
- Metabolomics 2
- Mass Spectrometry 14
- Flow Cytometry 1
- Immunohistochemistry 14
- Positron-Emission Tomography 32
- Magnetic Resonance Imaging 94
- Machine Learning 13
- Deep Learning 4
- Cohort Studies 41
- Genome-Wide Association Study 2
Paste an abstract
See which targets of this disease your abstract mentions, and go to the people working on them.
Matched in your browser only. The text is not sent, saved or logged.
Sources: ClinicalTrials.gov, EU CTR, OpenAlex, PubMed. Machine-matched links are labelled.